TEVA · Categories · Coverage
TEVA - Analyst coverage initiated
Teva Pharmaceutical Industries Limited (TEVA) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for TEVA
- Barclays initiated coverage on Teva Pharma with a new price targetBarclays initiated coverage of Teva Pharma with a rating of Overweight and set a new price target of $35.00
- Scotiabank initiated coverage on Teva Pharma with a new price targetScotiabank initiated coverage of Teva Pharma with a rating of Sector Outperform and set a new price target of $35.00
- Goldman initiated coverage on Teva Pharma with a new price targetGoldman initiated coverage of Teva Pharma with a rating of Buy and set a new price target of $24.00
- Truist initiated coverage on Teva Pharma with a new price targetTruist initiated coverage of Teva Pharma with a rating of Buy and set a new price target of $25.00
- HSBC Securities initiated coverage on Teva Pharma with a new price targetHSBC Securities initiated coverage of Teva Pharma with a rating of Buy and set a new price target of $13.00
- Morgan Stanley initiated coverage on Teva Pharma with a new price targetMorgan Stanley initiated coverage of Teva Pharma with a rating of Equal-Weight and set a new price target of $10.00